Cargando…
The Comparative Oncology Trials Consortium: Using Spontaneously Occurring Cancers in Dogs to Inform the Cancer Drug Development Pathway
Chand Khanna and colleagues describe the work of the Comparative Oncology Trials Consortium (COTC), which provides infrastructure and resources to integrate naturally occurring dog cancer models into the development of new human cancer drugs, devices, and imaging techniques.
Autores principales: | Gordon, Ira, Paoloni, Melissa, Mazcko, Christina, Khanna, Chand |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2753665/ https://www.ncbi.nlm.nih.gov/pubmed/19823573 http://dx.doi.org/10.1371/journal.pmed.1000161 |
Ejemplares similares
-
Launching a Novel Preclinical Infrastructure: Comparative Oncology Trials Consortium Directed Therapeutic Targeting of TNFα to Cancer Vasculature
por: Paoloni, Melissa C., et al.
Publicado: (2009) -
The Establishment of the Pfizer-Canine Comparative Oncology and Genomics Consortium Biospecimen Repository
por: Mazcko, Christina, et al.
Publicado: (2015) -
Rapamycin Pharmacokinetic and Pharmacodynamic Relationships in Osteosarcoma: A Comparative Oncology Study in Dogs
por: Paoloni, Melissa C., et al.
Publicado: (2010) -
A Comparative Oncology Study of Iniparib Defines Its Pharmacokinetic Profile and Biological Activity in a Naturally-Occurring Canine Cancer Model
por: Saba, Corey, et al.
Publicado: (2016) -
Creating Locally Relevant Health Information
por: Carter, Isabel
Publicado: (2005)